×
App Icon
The Standard e-Paper
Kenya’s Boldest Voice
★★★★ - on Play Store
Download App

GSK calls for research proposals into non-communicable diseases in Kenya, Sub-Saharan Africa

Nairobi-Kenya: GlaxoSmithKline (GSK) announced the third call for proposals as part of the Africa non-communicable diseases (NCD) Open Lab this week, strengthening the company’s commitment to much-needed scientific research into NCDs.  

The Africa NCD Open Lab is part of a series of investments GSK is making across Sub-Saharan Africa. The Open Lab, launched in 2014, aims to work in partnership with African researchers and academic groups to conduct research into NCDs such as cancer, diabetes, cardiovascular disease and chronic respiratory diseases. 

Premium Article

Get Full Access for Ksh299/Week.

Bold Reporting Takes Time, Courage and Investment. Stand With Us.
Continue Reading  →
What you get
  • Unlimited access to all premium content
  • Ad-free browsing experience
  • Mobile-optimised reading
  • Weekly newsletters & digests
Pay via
M - PESA
VISA
Airtel Money
Secure Payments Kenya's most trusted newsroom since 1902
Support Independent Journalism

Stand With Bold Journalism.
Stand With The Standard.

Journalism can't be free because the truth demands investment. At The Standard, we invest time, courage and skills to bring you accurate, factual and impactful stories. Subscribe today and stand with us in the pursuit of credible journalism.

Pay via
M - PESA
VISA
Airtel Money
Secure Payment Kenya's most trusted newsroom since 1902

Related Topics

GSK